Taprenepag 是一种有效的选择性前列腺素 E2 受体激动剂，EC50为 2.8 nM，可用于研究开角治疗高眼压和青光眼的试验。

Taprenepag (CP-544326) is a potent and selective prostaglandin E2 receptor agonist (EC50 = 2.8 nM). Taprenepag has been used in trials studying the treatment of Ocular Hypertension and Glaucoma, Open-Angle.

752187-80-7

C24H22N4O5S

478.52

CP-544326

DMSO:30 mg/mL
Powder: -20°C for 3 years
In solvent: -80°C for 2 years